Open-label pilot study of tofacitinib 2% for the treatment of refractory vitiligo

被引:41
作者
Mobasher, P. [1 ]
Guerra, R. [2 ]
Li, S. J. [2 ]
Frangos, J. [2 ]
Ganesan, A. K. [1 ]
Huang, V. [2 ,3 ]
机构
[1] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92717 USA
[2] Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA
[3] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1111/bjd.18606
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:1047 / 1049
页数:3
相关论文
共 5 条
  • [1] Tofacitinib Citrate for the Treatment of Vitiligo A Pathogenesis-Directed Therapy
    Craiglow, Brittany G.
    King, Brett A.
    [J]. JAMA DERMATOLOGY, 2015, 151 (10) : 1110 - 1112
  • [2] A Mouse Model of Vitiligo with Focused Epidermal Depigmentation Requires IFN-γ for Autoreactive CD8+ T-Cell Accumulation in the Skin
    Harris, John E.
    Harris, Tajie H.
    Weninger, Wolfgang
    Wherry, E. John
    Hunter, Christopher A.
    Turka, Laurence A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (07) : 1869 - 1876
  • [3] Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure
    Liu, Lucy Y.
    Strassner, James P.
    Refat, Maggi A.
    Harris, John E.
    King, Brett A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (04) : 675 - +
  • [4] A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
    McKesey, Jacqueline
    Pandya, Amit G.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (02) : 646 - 648
  • [5] Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib
    Rothstein, Brooke
    Joshipura, Deep
    Saraiya, Ami
    Abdat, Rana
    Ashkar, Huda
    Turkowski, Yana
    Sheth, Vaneeta
    Huang, Victor
    Au, Shiu Chung
    Kachuk, Courtney
    Dumont, Nicole
    Gottlieb, Alice B.
    Rosmarin, David
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : 1054 - +